Hsbc Holdings PLC Buys 217,394 Shares of Healthpeak Properties, Inc. $DOC

Hsbc Holdings PLC grew its stake in Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 7.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,262,602 shares of the real estate investment trust’s stock after buying an additional 217,394 shares during the quarter. Hsbc Holdings PLC’s holdings in Healthpeak Properties were worth $52,462,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the stock. WPG Advisers LLC grew its stake in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after acquiring an additional 1,197 shares in the last quarter. Advocate Investing Services LLC bought a new stake in shares of Healthpeak Properties in the fourth quarter worth $26,000. Elyxium Wealth LLC bought a new stake in shares of Healthpeak Properties in the fourth quarter worth $31,000. Clearstead Advisors LLC boosted its holdings in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after purchasing an additional 1,216 shares during the last quarter. Finally, CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties in the second quarter valued at $33,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

NYSE DOC opened at $21.85 on Monday. The firm has a market capitalization of $15.07 billion, a P/E ratio of 68.30, a price-to-earnings-growth ratio of 3.41 and a beta of 1.02. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The firm’s fifty day moving average price is $19.54 and its two-hundred day moving average price is $17.85. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $21.98.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same quarter last year, the firm posted $0.46 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, research analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on DOC shares. Scotiabank lifted their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, May 10th. Robert W. Baird lifted their target price on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target for the company. in a research report on Monday, May 11th. Finally, BMO Capital Markets raised their price target on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, June 15th. Three analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of “Hold” and a consensus price target of $19.93.

Read Our Latest Report on Healthpeak Properties

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Featured Stories

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.